Literature DB >> 18541412

Genetic variation in the DAOA gene complex: impact on susceptibility for schizophrenia and on cognitive performance.

Carolin Opgen-Rhein1, Todd Lencz, Katherine E Burdick, Andres H Neuhaus, Pamela DeRosse, Terry E Goldberg, Anil K Malhotra.   

Abstract

INTRODUCTION: The genetic region coding for d-amino acid oxidase activator (DAOA) is considered an intriguing susceptibility locus for schizophrenia. However, association studies have often resulted in conflicting findings, and the risk-conferring variants and their biological impact remain elusive. Our aim in this study was to investigate the relationship between DAOA variation and schizophrenia, and the influence of DAOA on cognitive performance.
METHODS: We analyzed block structure and association patterns of an approximately 173 kb region on chromosome 13q33, applying genotype data of 55 SNPs derived from Caucasian North American sample (178 cases, 144 healthy controls). Haplotypes were assigned using the program PHASE and frequencies compared between cases and controls. We applied MANOVA to investigate the relationship between the identified risk haplotype on cognitive performance.
RESULTS: We identified multiple haplotypes within the region containing the DAOA gene. Of these, one was significantly associated with schizophrenia, being over-represented in schizophrenia versus healthy controls. This haplotype was also associated with one aspect of cognitive performance, semantic fluency. Carriers of the risk haplotype showed better semantic fluency than non-carriers.
CONCLUSIONS: We report a significant effect of DAOA variation on risk for schizophrenia. Moreover, we identified a relationship between DAOA genetic variation and specific aspects of neurocognitive function. As the identified DAOA risk haplotype was associated with better performance on a semantic fluency measure, further work is required to identify the mechanism of DAOA action on CNS function, including the possibility of a role for balanced selection at this locus.

Entities:  

Mesh:

Year:  2008        PMID: 18541412      PMCID: PMC2605318          DOI: 10.1016/j.schres.2008.04.020

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  55 in total

1.  Inference of population structure using multilocus genotype data.

Authors:  J K Pritchard; M Stephens; P Donnelly
Journal:  Genetics       Date:  2000-06       Impact factor: 4.562

2.  A comparison of bayesian methods for haplotype reconstruction from population genotype data.

Authors:  Matthew Stephens; Peter Donnelly
Journal:  Am J Hum Genet       Date:  2003-10-20       Impact factor: 11.025

3.  Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia.

Authors:  Michael F Egan; Richard E Straub; Terry E Goldberg; Imtiaz Yakub; Joseph H Callicott; Ahmad R Hariri; Venkata S Mattay; Alessandro Bertolino; Thomas M Hyde; Cynthia Shannon-Weickert; Mayada Akil; Jeremy Crook; Radha Krishna Vakkalanka; Rishi Balkissoon; Richard A Gibbs; Joel E Kleinman; Daniel R Weinberger
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-13       Impact factor: 11.205

4.  A family-based study of the association between the G72/G30 genes and schizophrenia in the Chinese population.

Authors:  Fanggeng Zou; Chao Li; Shiwei Duan; Yonglan Zheng; Niufan Gu; Guoyin Feng; Yangling Xing; Jianguo Shi; Lin He
Journal:  Schizophr Res       Date:  2005-03-01       Impact factor: 4.939

5.  A search for specific and common susceptibility loci for schizophrenia and bipolar disorder: a linkage study in 13 target chromosomes.

Authors:  M Maziade; M A Roy; E Rouillard; L Bissonnette; J P Fournier; A Roy; Y Garneau; N Montgrain; A Potvin; D Cliche; C Dion; H Wallot; A Fournier; L Nicole; J C Lavallée; C Mérette
Journal:  Mol Psychiatry       Date:  2001-11       Impact factor: 15.992

6.  Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia.

Authors:  M F Egan; T E Goldberg; B S Kolachana; J H Callicott; C M Mazzanti; R E Straub; D Goldman; D R Weinberger
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-29       Impact factor: 11.205

Review 7.  G72/G30 in schizophrenia and bipolar disorder: review and meta-analysis.

Authors:  Sevilla D Detera-Wadleigh; Francis J McMahon
Journal:  Biol Psychiatry       Date:  2006-04-11       Impact factor: 13.382

Review 8.  Genes for schizophrenia? Recent findings and their pathophysiological implications.

Authors:  Paul J Harrison; Michael J Owen
Journal:  Lancet       Date:  2003-02-01       Impact factor: 79.321

Review 9.  Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence.

Authors:  P J Harrison; D R Weinberger
Journal:  Mol Psychiatry       Date:  2005-01       Impact factor: 15.992

10.  The G72/G30 gene complex and cognitive abnormalities in schizophrenia.

Authors:  Terry E Goldberg; Richard E Straub; Joseph H Callicott; Ahmad Hariri; Venkata S Mattay; Llewellyn Bigelow; Richard Coppola; Michael F Egan; Daniel R Weinberger
Journal:  Neuropsychopharmacology       Date:  2006-03-22       Impact factor: 7.853

View more
  10 in total

Review 1.  Metabolism of the neuromodulator D-serine.

Authors:  Loredano Pollegioni; Silvia Sacchi
Journal:  Cell Mol Life Sci       Date:  2010-03-02       Impact factor: 9.261

2.  Effect of D-amino acid oxidase activator (DAOA; G72) on brain function during verbal fluency.

Authors:  Diana P Prata; Sergio A Papagni; Andrea Mechelli; Cynthia H Y Fu; Joseph Kambeitz; Marco Picchioni; Fergus Kane; Sridevi Kalidindi; Colm McDonald; Eugenia Kravariti; Timothea Toulopoulou; Elvira Bramon; Muriel Walshe; Robin Murray; David A Collier; Philip K McGuire
Journal:  Hum Brain Mapp       Date:  2011-03-09       Impact factor: 5.038

3.  Genetic modulation of longitudinal change in neurocognitive function among adult glioma patients.

Authors:  Renke Zhou; Jeffrey S Wefel; Erik P Sulman; Nicholas S Boehling; Georgina N Armstrong; Spiridon Tsavachidis; Fu-Wen Liang; Carol J Etzel; Lisa S Kahalley; Brent J Small; Michael E Scheurer; Melissa L Bondy; Yanhong Liu
Journal:  J Neurooncol       Date:  2021-11-24       Impact factor: 4.130

4.  The DAOA/G30 locus and affective disorders: haplotype based association study in a polydiagnostic approach.

Authors:  Micha Gawlik; Ingeborg Wehner; Meinhard Mende; Sven Jung; Bruno Pfuhlmann; Michael Knapp; Gerald Stöber
Journal:  BMC Psychiatry       Date:  2010-07-29       Impact factor: 3.630

Review 5.  The impact of genetic research on our understanding of normal cognitive ageing: 1995 to 2009.

Authors:  Antony Payton
Journal:  Neuropsychol Rev       Date:  2009-09-19       Impact factor: 7.444

6.  Interaction between effects of genes coding for dopamine and glutamate transmission on striatal and parahippocampal function.

Authors:  Andreina Pauli; Diana P Prata; Andrea Mechelli; Marco Picchioni; Cynthia H Y Fu; Christopher A Chaddock; Fergus Kane; Sridevi Kalidindi; Colm McDonald; Eugenia Kravariti; Timothea Toulopoulou; Elvira Bramon; Muriel Walshe; Natascha Ehlert; Anna Georgiades; Robin Murray; David A Collier; Philip McGuire
Journal:  Hum Brain Mapp       Date:  2012-03-22       Impact factor: 5.038

Review 7.  d-Amino Acids and pLG72 in Alzheimer's Disease and Schizophrenia.

Authors:  Yu-Jung Cheng; Chieh-Hsin Lin; Hsien-Yuan Lane
Journal:  Int J Mol Sci       Date:  2021-10-09       Impact factor: 5.923

8.  The DAO gene is associated with schizophrenia and interacts with other genes in the Taiwan Han Chinese population.

Authors:  Hsin-Chou Yang; Chih-Min Liu; Yu-Li Liu; Chia-Wei Chen; Chien Ching Chang; Cathy S J Fann; Jen-Jie Chiou; Ueng-Cheng Yang; Chun-Houh Chen; Stephen V Faraone; Ming T Tsuang; Hai-Gwo Hwu
Journal:  PLoS One       Date:  2013-03-28       Impact factor: 3.240

9.  Effect of the G72 (DAOA) putative risk haplotype on cognitive functions in healthy subjects.

Authors:  Andreas Jansen; Sören Krach; Axel Krug; Valentin Markov; Thomas Eggermann; Klaus Zerres; Markus Thimm; Markus M Nöthen; Jens Treutlein; Marcella Rietschel; Tilo Kircher
Journal:  BMC Psychiatry       Date:  2009-09-24       Impact factor: 3.630

10.  Haplotype-based association analysis of general cognitive ability in Generation Scotland, the English Longitudinal Study of Ageing, and UK Biobank.

Authors:  David M Howard; Mark J Adams; Toni-Kim Clarke; Eleanor M Wigmore; Yanni Zeng; Saskia P Hagenaars; Donald M Lyall; Pippa A Thomson; Kathryn L Evans; David J Porteous; Reka Nagy; Caroline Hayward; Chris S Haley; Blair H Smith; Alison D Murray; G David Batty; Ian J Deary; Andrew M McIntosh
Journal:  Wellcome Open Res       Date:  2017-08-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.